DNTH vs OKE · rev $6.2M vs P/E 15, rev $21.70B
Dianthus Therapeutics Inc. (DNTH) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
DNTH currently screens at market cap $4.40B. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the DNTH and OKE stock pages for the full models.
Not investment advice.